| Autor: |
Macedo PE; Interdisciplinary Center for Biotechnology Research, Federal University of Pampa, São Gabriel, Brazil., Batista JES; Interdisciplinary Center for Biotechnology Research, Federal University of Pampa, São Gabriel, Brazil., Souza LR; Interdisciplinary Center for Biotechnology Research, Federal University of Pampa, São Gabriel, Brazil., Dafre AL; Department of Biochemistry, Federal University of Santa Catarina, Santa Catarina, Brazil., Farina M; Department of Biochemistry, Federal University of Santa Catarina, Santa Catarina, Brazil., Kuca K; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic., Posser T; Interdisciplinary Center for Biotechnology Research, Federal University of Pampa, São Gabriel, Brazil., Pinto PM; Interdisciplinary Center for Biotechnology Research, Federal University of Pampa, São Gabriel, Brazil., Boldo JT; Interdisciplinary Center for Biotechnology Research, Federal University of Pampa, São Gabriel, Brazil., Franco JL; Interdisciplinary Center for Biotechnology Research, Federal University of Pampa, São Gabriel, Brazil. |
| Abstrakt: |
The widely used insecticide chlorpyrifos (CP) is known to inhibit acetylcholinesterase (AChE) activity attributed to result in various neurological disorders and acetylcholine-dependent organ functions including heart, skeletal muscle, lung, gastrointestinal tract, and central nervous systems. Enzyme reactivators, such as oximes, are known to restore AChE activity and mitigate adverse effects. The identification of compounds that reactivate AChE constitute agents with important therapeutic beneficial effects in cases of pesticide poisoning. However, the screening of novel drugs using traditional models may raise ethical concerns. This study aimed to investigate the potential of Drosophila melanogaster as a model organism for screening AChE reactivators, with a focus on organophosphate poisoning. The efficacy of several oximes, including pralidoxime, trimedoxime, obidoxime, methoxime, HI-6, K027, and K048, against CP-induced AChE activity inhibition in D. melanogaster was determined in silico , in vitro , and in vivo experiments. Molecular docking studies indicated a strong interaction between studied oximes and the active-site gorge of AChE. Data showed that selected oximes (100 μM) are effective in the reactivation of AChE inhibited by CP (10 μM) in vitro . Finally, in vivo investigations demonstrated that selected oximes, pralidoxime and K048 (1.5 ppm), reversed the locomotor deficits, inhibition of AChE activity as well as lowered the mortality rates induced by CP (0.75 ppm). Our findings contribute to utilization of D. melanogaster as a robust model for determination of actions of identified new AChE inhibitory agents with more effective therapeutic properties that those currently in use in the clinical practice in treatment of AChE associated disorders. |
